Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|
Revenue | $101.5M | $177.0M | $122.5M | $48.0M | $274.5M | $17.7B | $19.3B | $6,848.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Moderna, Inc.'s last 12-month Revenue is $3,229.0M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Moderna, Inc.'s Revenue growth was (52.9%). The average annual Revenue growth rates for Moderna, Inc. have been (19.5%) over the past three years, 132.0% over the past five years.
Over the last year, Moderna, Inc.'s Revenue growth was (52.9%), which is lower than industry growth of 2.7%. It indicates that Moderna, Inc.'s Revenue growth is Bad.